AVPR1A and hepatorenal syndrome: As proof-of-concept, three genes encoding G protein-coupled receptors (SST3, SST5, and AVPR1A) that are current therapeutic targets in PH in the setting of acute variceal haemorrhage and hepatorenal syndrome were up-regulated (Figure 5).